Why the study?
Factor XI deficiency, or hemophilia C, is a rare inherited coagulopathy that requires a careful balance between bleeding and thrombotic risks, particularly in elderly patients with cardiovascular comorbidities such as atrial fibrillation.
Case Report (n=1)
No
This case report highlights a personalized, multidisciplinary approach using perioperative fresh frozen plasma for permanent pacemaker implantation and a reduced-dose direct oral anticoagulant regimen to balance bleeding and cardioembolic risks in an elderly patient with atrial fibrillation and congenital Factor XI deficiency.
Answers are grounded in this paper and cite their sources.
Individualized antithrombotic decisions remain essential in Factor XI deficiency with AF; leaves open optimal regimens pending prospective data.
Factor XI (FXI) deficiency, or hemophilia C, is a rare inherited coagulopathy requiring careful balance between bleeding and thrombotic risks, especially in elderly patients with cardiovascular comorbidities. We report an 85-year-old male with Parkinson’s disease presenting with new-onset arrhythmia and concomitant congenital FXI deficiency.
No takes yet. Share an insight, caveat, or question.
Marrone et al. (2026) conducted a case report in Hemophilia C (congenital Factor XI deficiency) with new-onset atrial fibrillation and tachycardia-bradycardia syndrome (n=1). Perioperative fresh frozen plasma continuous infusion and reduced-dose direct oral anticoagulant (DOAC) was evaluated on Perioperative hemostasis during permanent pacemaker implantation and long-term stroke prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: